SIFI SpA - Strategic SWOT Analysis Review
SIFI SpA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.
Scope
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
Highlights
SIFI SpA (SIFI) is an integrated ophthalmic company that focuses on eye care products. It develops, manufactures and markets pharmaceutical products, diagnostic instruments and surgical equipment for the prevention and treatment of ocular pathologies. SIFI develops its products in various dosage forms including ointments, eye drops, pills and capsules. Its products find application in the areas of corneal abrasions, cataract, glaucoma, infections, inflammation, dry eye, and retinopathies. It conducts research in the areas of diagnostics and surgery. SIFI operates directly in Italy, Spain, France, Romania, Mexico, and Turkey. SIFI is headquartered in Catania, Italy.
SIFI SpA Key Recent Developments
Jun 09,2021: SIFI to present at BIO Digital International Convention 2021
May 17,2021: SIFI and Bausch Health Russia announce strategic commercial partnership that will ensure greater access to important eye care medicines in Russia
Mar 22,2021: SIFI announces granting of marketing authorizations in Turkey
Dec 07,2020: SIFI appoints Jelle Kleijn as global head of acanthamoeba keratitis to globally lead the effort to deliver the first registered treatment for this rare sight-threatening parasitic eye infection
Mar 23,2020: Covid-19 emergency, SIFI provides Italian hospital units of ophthalmology with products to treat ocular discomfort and prevent potential risks of infection
Reasons to Buy
- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.
Note: Some sections may be missing if data is unavailable for the company.